SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Malcolm MacConmara, Ifeoma Nwadei, Allan D. Kirk, Transplantation of the Liver, 2015,

    CrossRef

  2. 2
    Greg J. McKenna, Göran B.G. Klintmalm, Transplantation of the Liver, 2015,

    CrossRef

  3. 3
    Greg J. McKenna, Göran B.G. Klintmalm, Transplantation of the Liver, 2015,

    CrossRef

  4. 4
    Taizo Hibi, Seigo Nishida, Junichiro Sageshima, David M. Levi, Phillip Ruiz, David Roth, Paul Martin, Koji Okabayashi, George W. Burke, Gaetano Ciancio, Andreas G. Tzakis, Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C, Transplant International, 2014, 27, 6
  5. 5
    Mauricio Garcia-Saenz-de-Sicilia, Marco A. Olivera-Martinez, Wendy J. Grant, David F. Mercer, Chen Baojjang, Alan Langnas, Timothy McCashland, Impact of Anti-Thymocyte Globulin During Immunosuppression Induction in Patients with Hepatitis C After Liver Transplantation, Digestive Diseases and Sciences, 2014, 59, 11, 2804

    CrossRef

  6. 6
    Mohamad Mohty, Andrea Bacigalupo, Faouzi Saliba, Andreas Zuckermann, Emmanuel Morelon, Yvon Lebranchu, New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity, Drugs, 2014, 74, 14, 1605

    CrossRef

  7. 7
    Susanne Beckebaum, Vito R. Cicinnati, Arnold Radtke, Iyad Kabar, Calcineurin inhibitors in liver transplantation – still champions or threatened by serious competitors?, Liver International, 2013, 33, 5
  8. 8
    Tadahiro Uemura, Lucas E. Nikkel, Christopher S. Hollenbeak, Varun Ramprasad, Eric Schaefer, Zakiyah Kadry, How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?, Transplant International, 2012, 25, 6
  9. 9
    Aaron James Chan, John R. Lake, Immunosuppression in HCV-positive liver-transplant recipients, Current Opinion in Organ Transplantation, 2012, 17, 6, 648

    CrossRef

  10. 10
    T. Uemura, V. Ramprasad, C. S. Hollenbeak, D. Bezinover, Z. Kadry, Liver Transplantation for Hepatitis C From Donation After Cardiac Death Donors: An Analysis of OPTN/UNOS Data, American Journal of Transplantation, 2012, 12, 4
  11. 11
    Marina Berenguer, José-Antonio Pons, Rabbit anti-thymocyte globulin in liver transplantation: All that glitters is not gold, but 1000 patients are so many to dazzle, Liver Transplantation, 2012, 18, 7
  12. 12
    Lionel Rostaing, Faouzi Saliba, Yvon Calmus, Sébastien Dharancy, Olivier Boillot, Review article: Use of induction therapy in liver transplantation, Transplantation Reviews, 2012, 26, 4, 246

    CrossRef

  13. 13
    G. Alex Bishop, Patrick D. Bertolino, David G. Bowen, Geoffrey W. McCaughan, Tolerance in liver transplantation, Best Practice & Research Clinical Gastroenterology, 2012, 26, 1, 73

    CrossRef

  14. 14
    Greg J. McKenna, Goran B. Klintmalm, The question of induction? Maybe not all antibodies are equal …*, Transplant International, 2011, 24, 7
  15. 15
    Luit Penninga, André Wettergren, Colin H Wilson, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Antibody induction versus corticosteroid induction for liver transplant recipients, The Cochrane Library,
  16. 16
    Luit Penninga, André Wettergren, Colin H Wilson, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients, The Cochrane Library,
  17. 17
    Nadim Mahmud, Burcin Taner, Nasimul Ahsan, Basiliximab (Simulect®) and Daclizumab (Zenapax®),
  18. 18
    Matthew H. Levine, Sandy Feng, Clinical Allograft Rejection Syndromes in Liver Transplantation,